Artiva Biotherapeutics, Inc. (ARTV) Stock Grade

About Artiva Biotherapeutics, Inc.'s fundamentals

Artiva Biotherapeutics is a biotechnology company with a market capitalization of $344.7 million that is currently unprofitable, reporting a net loss in its latest annual statement with a net margin of 0.0%. The company experienced a complete decline in revenue year-over-year with -100.0% revenue growth, indicating no active revenue generation in the most recent period. The company does not pay a dividend and operates without positive equity returns. Traditional valuation metrics like P/E ratio and return on equity are not applicable given the company's loss-making status.